RLBAX
Price
$38.17
Change
-$0.10 (-0.26%)
Updated
Sep 17 closing price
Net Assets
263.25B
STFBX
Price
$96.04
Change
-$0.03 (-0.03%)
Updated
Sep 17 closing price
Net Assets
2.59B
Interact to see
Advertisement

RLBAX vs STFBX

Header iconRLBAX vs STFBX Comparison
Open Charts RLBAX vs STFBXBanner chart's image
American Funds American Balanced R1
Price$38.17
Change-$0.10 (-0.26%)
VolumeN/A
Net Assets263.25B
State Farm Balanced
Price$96.04
Change-$0.03 (-0.03%)
VolumeN/A
Net Assets2.59B
RLBAX vs STFBX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
RLBAX vs. STFBX commentary
Sep 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RLBAX is a Buy and STFBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBAX has more cash in the bank: 263B vs. STFBX (2.59B). STFBX pays higher dividends than RLBAX: STFBX (2.18) vs RLBAX (1.15). RLBAX was incepted earlier than STFBX: RLBAX (23 years) vs STFBX (58 years). RLBAX (1.31) is less costly to investors than STFBX (0.18). RLBAX is a more actively managed with annual turnover of: 44.00 vs. STFBX (19.00). RLBAX (250) and STFBX (250) have matching initial minimum investment requirements. RLBAX annual gain was more profitable for investors over the last year : 8.68 vs. STFBX (4.26). RLBAX return over 5 years is better than : 38.76 vs. STFBX (36.38).
RLBAXSTFBXRLBAX / STFBX
Total Expense Ratio1.310.14936%
Annual Report Gross Expense Ratio1.310.18728%
Fund Existence23 years58 years-
Gain YTD12.51510.175123%
Front LoadN/AN/A-
Min. Initial Investment250250100%
Min. Initial Investment IRAN/AN/A-
Net Assets263B2.59B10,170%
Annual Yield % from dividends1.152.1853%
Returns for 1 year8.684.26204%
Returns for 3 years40.1731.30128%
Returns for 5 years38.7636.38107%
Returns for 10 years71.0979.5489%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ATRA11.650.14
+1.17%
Atara Biotherapeutics Inc.
DV12.970.04
+0.31%
DoubleVerify Holdings
JZ1.71N/A
N/A
Jianzhi Education Technology Group Company Limited
EBF18.13-0.04
-0.22%
Ennis
SQM43.35-0.30
-0.69%
Sociedad Quimica y Minera de Chile SA